Eastern Hepatobiliary Surgery Hospital

This study is testing a two-part treatment for advanced bile duct cancer (intrahepatic cholangiocarcinoma) that cannot be removed by surgery. It combines chemotherapy delivered directly to the liver (HAIC) with immunotherapy drugs (Durvalumab or Pembrolizumab). The main goal is t…

This study is testing whether giving two cancer drugs one after the other (sequential) works better or worse than giving them at the same time (concurrent) for people with advanced liver cancer who also have fatty liver disease. It will involve 20 participants and aims to see whi…

This study is testing a new type of personalized cell therapy for patients with advanced liver cancer that has come back or stopped responding to other treatments. Doctors will collect a patient's own immune cells, genetically modify them in a lab to better recognize and attack u…